Kowa - PharmaKB

Company Reports

Company Reports

Disease Reports

Disease Reports

Company ReportsKowa

Kowa

Download report

Favorite

Financial

Marketed Drugs

Clinical Trials

Financial

Stock price

No data

Company Revenue

No data

Revenue by Drug

Marketed Drugs

Therapeutic Areas:

All

Classification:

All

Include Generics:

Trade Name	Drug Name	Approved	Patent Expires	Indication
Livalo	Pitavastatin	2009-08-03	2024-2031	Hypercholesterolemia , Hypertriglyceridemia , Hyperlipoproteinemias
Seglentis	Celecoxib, Tramadol	2021-10-15	2029-2038	Ankylosing spondylitis , Rheumatoid arthritis , Osteoarthritis , Adenomatous polyposis coli , Dysmenorrhea , Hypertension , Coronary artery disease , Variant angina pectoris , Pain

Clinical Trials

Therapeutic Areas:

All

Classification:

All

Approval:

All

Status:

All

Phases:

All

Drug Name

Phase 1

Phase 2

Phase 3

Phase 4

Indication

metabolic syndrome

,

,

,

type 2 diabetes mellitus

,

diabetes mellitus

,

cardiovascular diseases

,

,

coronary disease

,

coronary artery disease

,

myocardial ischemia

,

,

,

hypercholesterolemia

,

hyperlipidemias

,

healthy volunteers/patients

,

hyperlipoproteinemias

,

renal insufficiency

,

alzheimer disease

liver cirrhosis

,

,

biliary liver cirrhosis

,

,

,

non-alcoholic fatty liver disease

,

,

,

,

retinal diseases

,

diabetic retinopathy

,

type 2 diabetes mellitus

,

diabetes mellitus

,

hyperlipidemias

,

hypercholesterolemia

coronary artery disease

,

myocardial ischemia

,

atherosclerosis

,

human influenza

,

gastroenteritis

,

rotavirus infections

,

hypersensitivity

type 2 diabetes mellitus

,

diabetes mellitus

renal insufficiency

,

type 2 diabetes mellitus

,

diabetes mellitus

,

diabetes complications

,

coronary disease

,

coronary artery disease

,

Tofogliflozin anhydrous

type 2 diabetes mellitus

,

diabetes mellitus

atopic dermatitis

,

,

,

,

hypercholesterolemia

,

healthy volunteers/patients

,

staphylococcal infections

,

renal insufficiency

,

chronic renal insufficiency

,

type 2 diabetes mellitus

,

diabetes mellitus

,

chronic kidney failure

,

kidney diseases

,

,

,

chronic hepatitis c

,

,

,

communicable diseases

,

chronic hepatitis

,

diabetes mellitus

,

type 2 diabetes mellitus

,

graft rejection

,

hematologic neoplasms

healthy volunteers/patients

,

pancreatic neoplasms

,

,

,

pharyngeal neoplasms

,

fallopian tube neoplasms

,

,

,

head and neck neoplasms

,

colorectal neoplasms

,

brain neoplasms

,

rectal neoplasms

,

renal cell carcinoma

,

myelodysplastic syndromes

,

,

,

squamous cell carcinoma

,

disease progression

,

retinal diseases

,

diabetic retinopathy

,

,

,

kidney neoplasms

,

squamous cell carcinoma of head and neck

,

systemic scleroderma

,

,

interstitial lung diseases

,

localized scleroderma

,

diffuse scleroderma

,

,

hemangiosarcoma

,

breast neoplasms

,

,

non-small-cell lung carcinoma

,

,

,

,

,

lupus nephritis

,

systemic lupus erythematosus

,

,

chronic urticaria

,

,

ovarian neoplasms

,

non-hodgkin lymphoma

,

diabetes mellitus

,

retinal vein occlusion

,

central venous catheters

,

triple negative breast neoplasms

,

stomach neoplasms

,

,

cerebral hemorrhage

,

,

neoplasm metastasis

,

rheumatoid arthritis

,

,

macular degeneration

,

wet macular degeneration

,

follicular lymphoma

,

,

,

cerebral intraventricular hemorrhage

,

large b-cell lymphoma diffuse

,

b-cell lymphoma

,

diabetes mellitus

,

type 2 diabetes mellitus

,

graft rejection

,

hematologic neoplasms

,

noise-induced hearing loss

,

,

parkinson disease

diabetes mellitus

,

type 2 diabetes mellitus

,

graft rejection

,

hematologic neoplasms

,

,

1

2

>

© 2020-2025 Collaborative Drug Discovery Inc. (CDD) | Terms of Use